The Effect of Oral Isosorbide Dinitrate in Prevention of Severe Pre-eclampcia in Patients with Mild Pre-eclampcia

Document Type : Original Article

Authors

1 Associate Professor of Obstetrics and Gynecology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

2 Resident of Obstetrics and Gynecology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

3 Intern of Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Introduction: Preeclampsia is a specific syndrome in pregnancy, which the definite cause and treatment is still not known. Isosorbide dinitrate, a nitric oxide donor vasodilator drug, is proposed to be effective in decreasing high blood pressure in pregnant women with severe preeclampsia. In this study, effect of oral isosorbide dinitrate in preventing of develop mild preeclampsia to severe preeclampsia in pregnant women was evaluated.
Methods: In a randomized clinical trial all pregnant women with mild preeclampsia who were admitted in prenatal ward of Akbarabadi or Firoozgar hospital of Tehran during March 2007- June 2009, were investigated. Individuals were investigated as cases (treated with oral isosorbide dinitrate) and controls (without any drug therapy) and compared based on systolic and diastolic blood pressure and time of developing severe preeclampsia. Data was analyzed using SPSS software (version 16) by t-test Independent.
Results: The difference between the systolic and diastolic blood pressures at the beginning of the study and after 24 hours were respectively 20.22±8.94 and 9.11±3.10 mmHg in the case group and 3.55±6.14 and 1.11±6.40 mmHg in control group (p<0.001). The mean delay in developing severe preeclampsia in case and control groups were respectively 29.89±27.34 and 7.89±8.15 days (p<0.001).
 
Conclusion: Oral isosorbide dinitrate delays developing severe preeclampsia in patients with mild preeclampsia and is effective in the treatment of hypertension due to mild preeclampsia.

Keywords


1. Mohamad Fathi D, Hisham S, Ahmad Farag Saied. Maternal &Fetal Evaluation in Patients with Preeclampsia
managed by Trans dermal Nitroglycerin Patch. Tanta Med Sci J 2007; 2 (1): 240-53
2. Saleh FM, Mohsmed MI, Ahmed MR, Tamer M, Dayem AE. Comparative study between the effect of
isosorbide dinitrate sublingual tablets versus oral nitroglycerine aerosol for lowering blood pressure in severe
pre-eclampsia. Bull Alex Fac Med 2009;45(2):269-79.
3. Leveno Jk, Cunningham FG, Grant NG, Alexandria JM. Bloom SL. Casey BM, Dashe JS, Sheffield JS, Yost
NP. Gestational hypertension and preeclampsia. William's manual of obstetrics and gynaecology, 21st edition,
McGrow-Hill companies 2003;339-41.
4. Meher S, Duley L. Nitric oxide for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev
2007;18(2):CD006490.
5. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell
disorder. Am J Obstet Gynecol 1989;161:1200-04.
6. Martínez-Abundis E, González-Ortiz M, Hernández-Salazar F, Huerta-J-Lucas MT. Sublingual isosorbide
dinitrate in the acute control of hypertension in patients with severe preeclampsia. Gynecol Obstet Invest
2000;50(1):39-42.
7. Maul H, Longo M, Saade GR, Garfield RE. Nitric oxide and its role during pregnancy: from ovulation to
delivery. Curr Pharm Des 2003;9(5):359-80.
8. De Pace V, Chiossi G, Facchinetti F. Clinical use of nitric oxide donors and L-arginine in obstetrics. J Matern
Fetal Neonatal Med 2007;20(8):569-79.
9. Molnár M, Sütö T, Tóth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces
sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet
Gynecol 1994;170(5 Pt 1):1458-66.
10. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar
to those of preeclampsia. Am J Obstet Gynecol 1993;169(5):1316-20.
 
11. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension
2008;51(4):960-69.
12. Vargas Ayala G, Salmerón Pérez I, Sánchez García AR, Jiménez Acevedo AL, Rubio Guerra AF. Efficacy of
isosorbide in aerosol form in the management of hypertensive crisis in severe preeclampsia. Ginecol Obstet
Mex. 1998;66:316-9.
13. Rubio-Guerra AF, Vargas-Ayala G, Lozano-Nuevo JJ, Narvaez-Rivera JL, Rodríguez-López L, CaballeroGonzález
FJ. Isosorbide aerosol: an option for the treatment of hypertensive crises. Angiology 1999;50(2):137-
42.
14. Rubio-Guerra AF, Vargas-Ayala G, Narváez-Rivera JL, Rodríguez-López L, Lozano-Nuevo JJ, Trejo-Orozco N.
Comparison between isosorbide dinitrate in aerosol and in tablets for the treatment of hypertensive emergencies.
Angiology 2001;52(2):131-5.
15. Cacciatore B, Halmesmäki E, Kaaja R, Teramo K, Ylikorkala O. Effects of transdermal nitroglycerin on
impedance to flow in the uterine, umbilical, and fetal middle cerebral arteries in pregnancies complicated by
preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 1998;179(1):140-5.
16. Nevo O, Thaler I, Shik V, Vortman T, Soustiel JF. The effect of isosorbide dinitrate, a donor of nitric oxide, on
maternal cerebral blood flow in gestational hypertension and preeclampsia. Am J Obstet Gynecol
2003;188(5):1360-5.
17. Vargas-Ayala G, Rubio-Guerra AF, Rodríguez-López L, Narváez-Rivera JL, Lozano-Nuevo JJ, Ramos-Brizuela
LM. Comparison between isosorbide dinitrate in aerosol and in tablet form for the treatment of hypertensive
emergencies in the elderly. Blood Press 2000;9(5):283-6.
18. Thaler I, Kahana H. The effect of a nitric oxide donor on fetal heart rate patterns in patients with hypertension.
Obstet Gynecol. 2002;100(5 Pt 1):987-91.
19. Mehta JL. Endothelium, coronary vasodilation, and organic nitrates. Am Heart J 1995;129(2):382-91.
20. Ducey J, Schulman H, Farmakides G, Rochelson B, Bracero L, Fleischer A, Guzman E, Winter D, Penny B. A
classification of hypertension in pregnancy based on Doppler velocimetry. Am J Obstet Gynecol
1987;157(3):680-5.
21. Ben-Ami M, Battino S, Weiner E, Shalev E. Duplex Doppler ultrasound in the evaluation of pregnancies
complicated by pregnancy-induced hypertension. Acta Obstet Gynecol Scand 1991;70(6):507-8.